Oncology & Cancer

Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia

Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or ...

Oncology & Cancer

Genetic study of familial leukemia solves 30-year medical mystery

A decades-old medical mystery has been solved by researchers at UC San Francisco and St. Jude Children's Research Hospital in Tennessee, who have discovered a pair of inherited genetic mutations underlying a familial blood ...

Oncology & Cancer

Roots of leukemia reveal possibility of predicting people at risk

Scientists have discovered that it is possible to identify people at high risk of developing acute myeloid leukaemia (AML) years before diagnosis. The researchers from Wellcome Sanger Institute, European Bioinformatics Institute ...

Oncology & Cancer

Study reveals secrets of "hot" and "cold" pancreatic cancer tumors

So-called "hot" tumors filled with T cells are often considered to be more sensitive to immunotherapy compared to "cold" tumors with fewer T cells, but a clear demonstration of why has eluded cancer biologists—until now. ...

Oncology & Cancer

Professor developing device to administer cancer drug

A new device under development by a nuclear engineering professor will allow doctors to dispense accurate dosages of a drug made with actinium-225, an isotope that has been shown to be effective in treating—and curing—myeloid ...

page 38 from 40